Log in

Start Your Membership Now

About 71% of people with type 2 diabetes who used an artificial intelligence (AI)-supported health and lifestyle coaching program reduced their hemoglobin A1c level (HbA1c) to 6.5%, without taking glucose-lowering medications other than metformin, according to a recent study. In a comparison group that received usual care, 2.4% reduced their HbA1c following the same medication patterns.

The AI system used in the study, the Twin Precision Treatment system, bundles sensors and coaching to generate personalized recommendations based on data from continuous glucose monitors and other wearable Bluetooth-enabled technologies. Tracked biometrics from wearable sensors include weight . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Tagged As: